Shareholders' equity · 2017–2025

Phathom Pharmaceuticals shareholders' equity

−$438M−$185M · FY2025

Phathom Pharmaceuticals (PHAT) reported −$438M in shareholders' equity for fiscal 2025, −$185M from the year before.

$02017−$1.3M2018$228M2019$194M2020$72.2M2021−$74.8M2022−$72.8M2023−$254M2024−$438M2025
Phathom Pharmaceuticals — Shareholders' equity, 2017–2025
Fiscal yearShareholders' equityChangeFiling
FY20252025-12-31−$438M−$185MOpen →
FY20242024-12-31−$254M−$181MOpen →
FY20232023-12-31−$72.8M+$2.1MOpen →
FY20222022-12-31−$74.8M−$147MOpen →
FY20212021-12-31$72.2M−62.9%Open →
FY20202020-12-31$194M−14.8%Open →
FY20192019-12-31$228M+$229MOpen →
FY20182018-12-31−$1.3M−$1.3MOpen →
FY20172017-12-31$0—Open →

Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

Shareholders' equity at companies of similar size

Full ranking by shareholders' equity →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Phathom Pharmaceuticals shareholders' equity |url=https://companiesranked.com/en/company/phathom-pharmaceuticals/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Phathom Pharmaceuticals shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/phathom-pharmaceuticals/shareholders-equity

BibTeX

@misc{companiesranked-en-company-phathom-pharmaceuticals-shareholders-equity-2026,
  author       = {{CompaniesRanked}},
  title        = {{Phathom Pharmaceuticals shareholders' equity}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/phathom-pharmaceuticals/shareholders-equity}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001193125-26-324867 · July 30, 2026

{{cite web |title=Phathom Pharmaceuticals shareholders' equity — 10-Q (0001193125-26-324867) |url=https://www.sec.gov/Archives/edgar/data/1783183/000119312526324867/phat-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-30}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Phathom Pharmaceuticals overview